 | • レポートコード：MRC23Q36118 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、81ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の侵襲性真菌感染症診断市場について調査・分析し、世界の侵襲性真菌感染症診断市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ガラクトマンナン（GM）試験、（1,3）-β-D-グルカン（G）試験）、用途別セグメント分析（病院、研究所）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Associates of Cape Cod, Inc.、IMMY、BioRad、Beijing Gold Mountainriver Tech Development Co.,Ltd.、Dynamiker Biotechnology (Tianjin) Co., Ltd.、Charles River Laboratories International, Inc.、Autobio Diagnostics Co.,Ltd.などが含まれています。 世界の侵襲性真菌感染症診断市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、侵襲性真菌感染症診断市場規模を推定する際に考慮しました。本レポートは、侵襲性真菌感染症診断の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、侵襲性真菌感染症診断に関するビジネス上の意思決定に役立てることを目的としています。 ・侵襲性真菌感染症診断市場の概要 - 侵襲性真菌感染症診断のタイプ別セグメント - 世界の侵襲性真菌感染症診断市場規模：タイプ別分析（ガラクトマンナン（GM）試験、（1,3）-β-D-グルカン（G）試験） - 侵襲性真菌感染症診断の用途別セグメント - 世界の侵襲性真菌感染症診断市場規模：用途別分析（病院、研究所） - 世界の侵襲性真菌感染症診断市場規模予測（2018年-2029年） ・侵襲性真菌感染症診断市場の成長トレンド - 侵襲性真菌感染症診断の地域別市場規模（2018年-2029年） - 侵襲性真菌感染症診断市場ダイナミクス - 侵襲性真菌感染症診断の業界動向 - 侵襲性真菌感染症診断市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ガラクトマンナン（GM）試験、（1,3）-β-D-グルカン（G）試験 - 世界の侵襲性真菌感染症診断のタイプ別市場規模（2018年-2023年） - 世界の侵襲性真菌感染症診断のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、研究所 - 世界の侵襲性真菌感染症診断の用途別市場規模（2018年-2023年） - 世界の侵襲性真菌感染症診断の用途別市場規模（2024年-2029年） ・侵襲性真菌感染症診断の地域別市場規模 - 北米の侵襲性真菌感染症診断市場規模（2018年-2029年） - アメリカの侵襲性真菌感染症診断市場規模（2018年-2029年） - ヨーロッパの侵襲性真菌感染症診断市場規模（2018年-2029年） - アジア太平洋の侵襲性真菌感染症診断市場規模（2018年-2029年） - 中国の侵襲性真菌感染症診断市場規模（2018年-2029年） - 日本の侵襲性真菌感染症診断市場規模（2018年-2029年） - 韓国の侵襲性真菌感染症診断市場規模（2018年-2029年） - インドの侵襲性真菌感染症診断市場規模（2018年-2029年） - オーストラリアの侵襲性真菌感染症診断市場規模（2018年-2029年） - 中南米の侵襲性真菌感染症診断市場規模（2018年-2029年） - 中東・アフリカの侵襲性真菌感染症診断市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Associates of Cape Cod, Inc.、IMMY、BioRad、Beijing Gold Mountainriver Tech Development Co.,Ltd.、Dynamiker Biotechnology (Tianjin) Co., Ltd.、Charles River Laboratories International, Inc.、Autobio Diagnostics Co.,Ltd. ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Invasive Fungal Infection Diagnosis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Invasive Fungal Infection Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Invasive Fungal Infection Diagnosis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Invasive Fungal Infection Diagnosis in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Invasive Fungal Infection Diagnosis include Associates of Cape Cod, Inc., IMMY, BioRad, Beijing Gold Mountainriver Tech Development Co.,Ltd., Dynamiker Biotechnology (Tianjin) Co., Ltd., Charles River Laboratories International, Inc. and Autobio Diagnostics Co.,Ltd., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Invasive Fungal Infection Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Invasive Fungal Infection Diagnosis.
The Invasive Fungal Infection Diagnosis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Invasive Fungal Infection Diagnosis market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Invasive Fungal Infection Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Associates of Cape Cod, Inc.
IMMY
BioRad
Beijing Gold Mountainriver Tech Development Co.,Ltd.
Dynamiker Biotechnology (Tianjin) Co., Ltd.
Charles River Laboratories International, Inc.
Autobio Diagnostics Co.,Ltd.
Segment by Type
Galactomannan(GM) Test
(1,3)-beta-D-Glucan(G) Test
Segment by Application
Hospital
Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Invasive Fungal Infection Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Invasive Fungal Infection Diagnosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Galactomannan(GM) Test
1.2.3 (1,3)-beta-D-Glucan(G) Test
1.3 Market by Application
1.3.1 Global Invasive Fungal Infection Diagnosis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Laboratory
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Invasive Fungal Infection Diagnosis Market Perspective (2018-2029)
2.2 Invasive Fungal Infection Diagnosis Growth Trends by Region
2.2.1 Global Invasive Fungal Infection Diagnosis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Invasive Fungal Infection Diagnosis Historic Market Size by Region (2018-2023)
2.2.3 Invasive Fungal Infection Diagnosis Forecasted Market Size by Region (2024-2029)
2.3 Invasive Fungal Infection Diagnosis Market Dynamics
2.3.1 Invasive Fungal Infection Diagnosis Industry Trends
2.3.2 Invasive Fungal Infection Diagnosis Market Drivers
2.3.3 Invasive Fungal Infection Diagnosis Market Challenges
2.3.4 Invasive Fungal Infection Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Invasive Fungal Infection Diagnosis Players by Revenue
3.1.1 Global Top Invasive Fungal Infection Diagnosis Players by Revenue (2018-2023)
3.1.2 Global Invasive Fungal Infection Diagnosis Revenue Market Share by Players (2018-2023)
3.2 Global Invasive Fungal Infection Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Invasive Fungal Infection Diagnosis Revenue
3.4 Global Invasive Fungal Infection Diagnosis Market Concentration Ratio
3.4.1 Global Invasive Fungal Infection Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Invasive Fungal Infection Diagnosis Revenue in 2022
3.5 Invasive Fungal Infection Diagnosis Key Players Head office and Area Served
3.6 Key Players Invasive Fungal Infection Diagnosis Product Solution and Service
3.7 Date of Enter into Invasive Fungal Infection Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Invasive Fungal Infection Diagnosis Breakdown Data by Type
4.1 Global Invasive Fungal Infection Diagnosis Historic Market Size by Type (2018-2023)
4.2 Global Invasive Fungal Infection Diagnosis Forecasted Market Size by Type (2024-2029)
5 Invasive Fungal Infection Diagnosis Breakdown Data by Application
5.1 Global Invasive Fungal Infection Diagnosis Historic Market Size by Application (2018-2023)
5.2 Global Invasive Fungal Infection Diagnosis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Invasive Fungal Infection Diagnosis Market Size (2018-2029)
6.2 North America Invasive Fungal Infection Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Invasive Fungal Infection Diagnosis Market Size by Country (2018-2023)
6.4 North America Invasive Fungal Infection Diagnosis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Invasive Fungal Infection Diagnosis Market Size (2018-2029)
7.2 Europe Invasive Fungal Infection Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Invasive Fungal Infection Diagnosis Market Size by Country (2018-2023)
7.4 Europe Invasive Fungal Infection Diagnosis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Invasive Fungal Infection Diagnosis Market Size (2018-2029)
8.2 Asia-Pacific Invasive Fungal Infection Diagnosis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Invasive Fungal Infection Diagnosis Market Size by Region (2018-2023)
8.4 Asia-Pacific Invasive Fungal Infection Diagnosis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Invasive Fungal Infection Diagnosis Market Size (2018-2029)
9.2 Latin America Invasive Fungal Infection Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Invasive Fungal Infection Diagnosis Market Size by Country (2018-2023)
9.4 Latin America Invasive Fungal Infection Diagnosis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Invasive Fungal Infection Diagnosis Market Size (2018-2029)
10.2 Middle East & Africa Invasive Fungal Infection Diagnosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Invasive Fungal Infection Diagnosis Market Size by Country (2018-2023)
10.4 Middle East & Africa Invasive Fungal Infection Diagnosis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Associates of Cape Cod, Inc.
11.1.1 Associates of Cape Cod, Inc. Company Detail
11.1.2 Associates of Cape Cod, Inc. Business Overview
11.1.3 Associates of Cape Cod, Inc. Invasive Fungal Infection Diagnosis Introduction
11.1.4 Associates of Cape Cod, Inc. Revenue in Invasive Fungal Infection Diagnosis Business (2018-2023)
11.1.5 Associates of Cape Cod, Inc. Recent Development
11.2 IMMY
11.2.1 IMMY Company Detail
11.2.2 IMMY Business Overview
11.2.3 IMMY Invasive Fungal Infection Diagnosis Introduction
11.2.4 IMMY Revenue in Invasive Fungal Infection Diagnosis Business (2018-2023)
11.2.5 IMMY Recent Development
11.3 BioRad
11.3.1 BioRad Company Detail
11.3.2 BioRad Business Overview
11.3.3 BioRad Invasive Fungal Infection Diagnosis Introduction
11.3.4 BioRad Revenue in Invasive Fungal Infection Diagnosis Business (2018-2023)
11.3.5 BioRad Recent Development
11.4 Beijing Gold Mountainriver Tech Development Co.,Ltd.
11.4.1 Beijing Gold Mountainriver Tech Development Co.,Ltd. Company Detail
11.4.2 Beijing Gold Mountainriver Tech Development Co.,Ltd. Business Overview
11.4.3 Beijing Gold Mountainriver Tech Development Co.,Ltd. Invasive Fungal Infection Diagnosis Introduction
11.4.4 Beijing Gold Mountainriver Tech Development Co.,Ltd. Revenue in Invasive Fungal Infection Diagnosis Business (2018-2023)
11.4.5 Beijing Gold Mountainriver Tech Development Co.,Ltd. Recent Development
11.5 Dynamiker Biotechnology (Tianjin) Co., Ltd.
11.5.1 Dynamiker Biotechnology (Tianjin) Co., Ltd. Company Detail
11.5.2 Dynamiker Biotechnology (Tianjin) Co., Ltd. Business Overview
11.5.3 Dynamiker Biotechnology (Tianjin) Co., Ltd. Invasive Fungal Infection Diagnosis Introduction
11.5.4 Dynamiker Biotechnology (Tianjin) Co., Ltd. Revenue in Invasive Fungal Infection Diagnosis Business (2018-2023)
11.5.5 Dynamiker Biotechnology (Tianjin) Co., Ltd. Recent Development
11.6 Charles River Laboratories International, Inc.
11.6.1 Charles River Laboratories International, Inc. Company Detail
11.6.2 Charles River Laboratories International, Inc. Business Overview
11.6.3 Charles River Laboratories International, Inc. Invasive Fungal Infection Diagnosis Introduction
11.6.4 Charles River Laboratories International, Inc. Revenue in Invasive Fungal Infection Diagnosis Business (2018-2023)
11.6.5 Charles River Laboratories International, Inc. Recent Development
11.7 Autobio Diagnostics Co.,Ltd.
11.7.1 Autobio Diagnostics Co.,Ltd. Company Detail
11.7.2 Autobio Diagnostics Co.,Ltd. Business Overview
11.7.3 Autobio Diagnostics Co.,Ltd. Invasive Fungal Infection Diagnosis Introduction
11.7.4 Autobio Diagnostics Co.,Ltd. Revenue in Invasive Fungal Infection Diagnosis Business (2018-2023)
11.7.5 Autobio Diagnostics Co.,Ltd. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details